| 1 |
31686598 | Severe and prolonged cyclophosphamide-induced hepatotoxicity in a breast cancer patient carrying a CYP2B6*7 variant. | 2019 Nov |
1 |
| 2 |
24387105 | Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells. | 2014 Jan 23 |
3 |
| 3 |
24677340 | Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity. | 2014 Mar 21 |
4 |
| 4 |
19224214 | Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma. | 2009 Sep |
1 |
| 5 |
18496131 | Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide. | 2008 Jun |
1 |
| 6 |
16614850 | RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide. | 2007 Jan |
1 |
| 7 |
12604187 | Antisense oligonucleotides against aldehyde dehydrogenase 3 inhibit hepatoma cell proliferation by affecting MAP kinases. | 2003 Feb 1 |
2 |
| 8 |
11914911 | Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. | 2002 Apr |
6 |
| 9 |
11306049 | Three different stable human breast adenocarcinoma sublines that overexpress ALDH3A1 and certain other enzymes, apparently as a consequence of constitutively upregulated gene transcription mediated by transactivated EpREs (electrophile responsive elements) present in the 5'-upstream regions of these genes. | 2001 Jan 30 |
1 |
| 10 |
11320670 | Primary breast tumor levels of suspected molecular determinants of cellular sensitivity to cyclophosphamide, ifosfamide, and certain other anticancer agents as predictors of paired metastatic tumor levels of these determinants. Rational individualization of cancer chemotherapeutic regimens. | 2001 Mar |
1 |
| 11 |
10856427 | Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3. | 2000 Aug 1 |
2 |
| 12 |
10469894 | Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines. | 1999 Aug |
1 |
| 13 |
9815579 | Cellular levels of class 1 and class 3 aldehyde dehydrogenases and certain other drug-metabolizing enzymes in human breast malignancies. | 1997 Nov |
1 |
| 14 |
8654195 | Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide. | 1995 Oct |
2 |